These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 340084)

  • 1. Radiosensitizers in the treatment of squamous cell carcinoma of the head and neck.
    Dische S
    Clin Otolaryngol Allied Sci; 1977 Nov; 2(4):403-9. PubMed ID: 340084
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of locally advanced head and neck cancer with misonidazole, hyperbaric oxygen and irradiation: an interim report.
    Sealy R; Cridland S
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1721-3. PubMed ID: 6384161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irradiation with misonidazole and hyperbaric oxygen: final report on a randomized trial in advanced head and neck cancer.
    Sealy R; Cridland S; Barry L; Norris R
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1343-6. PubMed ID: 3531113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiosensitization of hypoxic tumor cells with special reference to head and neck cancers].
    Kogelnik HD
    Wien Klin Wochenschr; 1983 Aug; 95(15):515-8. PubMed ID: 6636784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxic Cell Radiosensitization in Head and Neck Squamous Cell Carcinoma: Running Out of Air.
    Morse RT; Mell LK
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):783-785. PubMed ID: 38851276
    [No Abstract]   [Full Text] [Related]  

  • 6. Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome: in regard to Evans et al. (Int J Radiat Oncol Biol Phys 2007;69:1024-1031).
    Bussink J; van der Kogel AJ; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1616. PubMed ID: 18374238
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperfractionated radiotherapy with or without misonidazole: results of a prospective randomized study in stage III-IV squamous cell carcinoma of the head and neck.
    Panis X; Nguyen TD; Froissart D; Demange L
    Int J Radiat Oncol Biol Phys; 1984 Oct; 10(10):1845-9. PubMed ID: 6386760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of head and neck cancer with hybaroxic radiotherapy.
    Wildermuth O
    Proc Natl Cancer Conf; 1970; 6():639-44. PubMed ID: 5458128
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of locally advanced cancer of the head and neck with intra-arterial cytotoxics, cobalt, and hyperbaric oxygen therapy.
    Sealy R; Helman P; Greenstein A; Shepstone B
    Cancer; 1974 Sep; 34(3):497-500. PubMed ID: 4855130
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of metronidazole on the radiosensitivity of Guerin's carcinoma during its growth].
    Rudakov NP; Kindzel'skiĭ LP; Zlochevskaia LL
    Med Radiol (Mosk); 1985 Mar; 30(3):76-7. PubMed ID: 3982262
    [No Abstract]   [Full Text] [Related]  

  • 11. Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer.
    Bakowski MT; Macdonald E; Mould RF; Cawte P; Sloggem J; Barrett A; Dalley V; Newton KA; Westbury G; James SE; Hellmann K
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):115-9. PubMed ID: 344287
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiosensitization of hypoxic tumor cells by simultaneous administration of hyperthermia and nitroimidazoles.
    Hofer KG; Hofer MG; Ieracitano J; McLaughlin WH
    Radiat Res; 1977 May; 70(2):362-77. PubMed ID: 860011
    [No Abstract]   [Full Text] [Related]  

  • 13. First analysis of tumor regression for the European randomized trial of etanidazole combined with radiotherapy in head and neck carcinomas.
    Chassagne D; Charreau I; Sancho-Garnier H; Eschwege F; Malaise EP
    Int J Radiat Oncol Biol Phys; 1992; 22(3):581-4. PubMed ID: 1531218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma.
    De Schutter H; Kimpe M; Isebaert S; Nuyts S
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):904-12. PubMed ID: 19215824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical study to assess chlorpromazine as hypoxic cell sensitizer in head & neck cancer treated with conventional radiation.
    Huilgol NG; Chatterjee N; Singh BB
    Indian J Cancer; 1998 Sep; 35(3):97-100. PubMed ID: 10226398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic cell radiosensitizers.
    Fowler JF
    Strahlentherapie Sonderb; 1978; 75():12-9. PubMed ID: 400196
    [No Abstract]   [Full Text] [Related]  

  • 17. NIMRAD - a phase III trial to investigate the use of nimorazole hypoxia modification with intensity-modulated radiotherapy in head and neck cancer.
    Thomson D; Yang H; Baines H; Miles E; Bolton S; West C; Slevin N
    Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):344-7. PubMed ID: 24685344
    [No Abstract]   [Full Text] [Related]  

  • 18. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
    Leonard CE; Chan DC; Chou TC; Kumar R; Bunn PA
    Cancer Res; 1996 Nov; 56(22):5198-204. PubMed ID: 8912857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does hyperbaric oxygen have a future in radiation therapy?
    Henk JM
    Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1125-8. PubMed ID: 7028699
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperbaric oxygen therapy.
    Feldmeier JJ; Court WS; Davolt DA; Stegmann B; Heimbach RD; Sheffield PT
    Otolaryngol Head Neck Surg; 1997 Jun; 116(6 Pt 1):703-4. PubMed ID: 9215393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.